(1-Isobutyl-1H-pyrazol-4-yl)boronic acid, 95.0%, 1g

2,5-Dioxopyrrolidin-1-yl 2-(prop-2-yn-1-yloxy)acetate, 98%, 100mg

1H-indazol-5-ol, 98%, 500g

methyl 4-hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylate, 97%, 5g

2,5-Dioxopyrrolidin-1-yl 2-{2-[(2,5-dioxopyrrolidin-1-yl)oxy]-2-oxoethoxy}acetate, 98.0%, 1g

N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide, 98%, 50mg

2-(4-((tert-Butoxycarbonyl)amino)cyclohexyl)acetic acid, 95%, 25g

2-methyl-1,2,3,4-tetrahydroquinoxaline, 95.0%, 100mg

3,5-Dibromo-4-methyl pyridine-2-ol, 95.0%, 10g

4-Bromo-6-methoxy-1H-indole, 95.0%, 25g

4-Chloro-1H-pyrrolo[3,2-c]pyridine, 95.0%, 5g

2,2-Dimethylpent-4-ynoic acid, 95.0%, 5g

Lead(II) Acetate [for Perovskite precursor]>98.0%(T)1g